Lacosamide Oral Solution
Product Images NDC 82983-427

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide Oral Solution (NDC 82983-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajenat Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

Each mL of this product contains 10 mg of lacosamide, USP. The usual dosage information can be found in the package insert. It should be stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Make sure not to freeze it. Any unused product should be discarded after six months of opening the bottle. It is important to keep this medication out of reach of children and to dispense it in the original container as described. Additionally, pharmacists are advised to provide the accompanying Medication Guide to each patient. This product is an Oral Solution, USP and is distributed by Ajenat Pharmaceuticals in Tampa, FL, USA.*

FDA Label Image

Lacofig1 (Laco Fig 1)

FDA Label Image

Lacofig2a (Laco Fig 2a)

This is information on responder rate percentages and the proportion of patients based on responder rate for Lacosamide Oral Solution and placebo groups in studies 2, 3, and 4. It includes data for different dosages of Lacosamide and shows improvement, worsening, and percentage breakdown for different responder rates. The figures help in understanding the efficacy and impact of Lacosamide at various dosage levels.*

FDA Label Image

Lacostructure (Laco Structur)

FDA Label Image

Lacofig3 (Lacofig3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.